Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?
By B. Iung, A. Cachier, G. Baron, D. Messika‐Zeitoun, F. Delahaye, P. Tornos, C. Gohlke-Bärwolf, E. Boersma, Philippe Ravaud, A. Vahanian. European Heart Journal, 2005
1,183 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/be52cfbfc24ba075df5bc9017968503aaccafa35
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. (2014, background): “A significant number of patients with severe aortic stenosis, however, are not candidates for SAVR, due to pre-existing comorbidities, frailty, and disabilities (3).”
- Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. (2007, neutral): “Valve in valve placement, n (%) 2 (2) 0 2 (6)”
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, methodology): “Finally, data from the Euro Heart Survey on VHD [4, 5], confirmed by other clinical trials, show that there is a real gap between the existing guidelines and their effective application [6–9].”
- Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. (2011, background): “As a consequence, 30% of these patients with severe symptomatic aortic stenosis are currently not operated.(3)”
- Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. (2013, neutral): “11 operative risk, advanced age, comorbidities, and patient preference (21,22).”
- Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, neutral): “Nevertheless, a large percentage of suitable candidates are currently not referred for surgery.(4,6)”